Therepi: A Replenishable Implanted Epicardial Reservoir

Seema Chawla; Chetna Sharma

doi:10.37591/rrjohp.v9i2.1532

Abstract

The healthcare technology has been advancing at such a high pace which was not expected some years back. This paper is an attempt to introduce not so known, still existing and in-development phase, techniques which can revolutionize the healthcare industry in different domains. The recent technological development in coronary therapies have shown a great promise in restoring the abnormalities present in the heart after the patient experiences heart attack; certain amount of scarring in the myocardial still remains prominent. The removal of scarring along with restoration of complete function of the cardiac could extinguish the series of events which resulted in heart failure. It is believed that the vehicles for biomaterial delivery increases the cellular retention of the cardiac with the increase in rate of survival in comparison to other therapies, thus opening new paradigms for future studies using this kind of delivery vehicle. Moreover, the deliveries of cell show that multiple administrations are therapeutically more effective in comparison to single doses in case of heart failure animal models. Any system offering multiple administrations without the requirement of multiple surgeries so far has not yet come into existence which is the main driving force to develop the design for the “Therepi”. Keywords: Therepi, heart attack, paradigmCite this ArticleSharma C, Chawla S. Therepi: A Replenishable Implanted Epicardial Reservoir. Research & Reviews: A Journal of Health Professions. 2019; 9(2): 12–16p.